Ruby Hall Clinic partners with MedLern

IMT News Desk
IMT News Desk
· 2 min read
Team of young nurses learning the practice from a doctor expert in the cabinet, emphasizing health care management and diagnostics in a facility. African american residents examine x rays.

Strengthens clinical excellence and workforce development across

Pune-based MedLern, healthcare training and workforce enablement platform, has announced a strategic partnership with Ruby Hall Clinic. This collaboration forms a key pillar of Ruby Hall Clinic’s digital transformation journey and aims to strengthen clinical, operational, and compliance-related training across the hospital network.

By integrating MedLern’s digital-first learning solutions with Ruby Hall Clinic’s strategic focus on workforce development, the partnership seeks to deliver structured, high-impact training programs seamlessly across a large and diverse workforce. The initiative is designed to ensure consistency, scalability, and measurable outcomes in hospital training, reinforcing Ruby Hall Clinic’s commitment to excellence in care and patient safety.

As part of the collaboration, MedLern’s advanced learning and development (L&D) platform will be deployed across Ruby Hall Clinic locations, enabling clinicians, nurses, technicians, and support staff to learn, practice, and grow through a unified digital ecosystem. The platform offers personalized learning pathways, interactive case-based modules, simulation-supported practice scenarios, and competency-based assessments tailored to the needs of high-performing hospitals.

Behram Khodaiji, CEO, Ruby Hall Clinic, Pune, said, “Ruby Hall Clinic has always believed that the foundation of exceptional patient care lies in the continuous growth and competency of our people. Partnering with MedLern allows us to bring a more organized, technology-supported approach to training, ensuring our teams are consistently updated and aligned with the highest standards of clinical practice.”

Col Denu Thomas, Group Head HR, Ruby Hall Clinic, Pune, said: “At Ruby Hall Clinic, building a future-ready healthcare workforce is a strategic priority. This partnership with MedLern strengthens our ability to deliver structured, standardized, and continuous learning across roles and locations. By leveraging digital learning and real-time insights, we can better support our teams in developing critical skills, improving compliance, and maintaining consistent clinical excellence, while ensuring learning remains seamlessly integrated into daily practice.”

Deepak Sharma, CEO and Co-founder, MedLern, shared: “Ruby Hall Clinic has set benchmarks in quality healthcare for decades, and we are proud to support their vision for ongoing professional development. Our focus is to make learning accessible, relevant, and practice-oriented so that staff can apply knowledge directly at the bedside. This partnership will strengthen skill development, enhance consistency, and ultimately drive improved outcomes for patients.”

Read Next

India successfully validates the first indigenous HPV test for Cervical Cancer screening
News
June 13, 2026

India successfully validates the first indigenous HPV test for Cervical Cancer screening

India has achieved a significant milestone in cervical cancer prevention with the successful validation of the country’s first indigenous HPV DNA tests, which meet international standards for cervical cancer screening. Published in the International Journal of Cancer, a multicentre study involving leading Indian and international institutions found that Molbio Diagnostics Truenat HPV-HR Plus met the […]
Article by: IMT News Desk
Glenmark Launches Winlevi® in Key European Markets for the Treatment of Acne Vulgaris
News
June 12, 2026

Glenmark Launches Winlevi® in Key European Markets for the Treatment of Acne Vulgaris

Glenmark Specialty S.A. (GSSA), a wholly owned subsidiary of Glenmark Pharmaceuticals Ltd., has announced the launch of Winlevi® (clascoterone 10 mg/g cream) across key markets in Europe. This follows the grant of marketing authorization of the product for the treatment of acne vulgaris in both adults and adolescents aged 12 to <18 years (with usage in […]
Article by: IMT News Desk
Thyrocare Expands Its Presence in Prayagraj with the Launch of Its New Diagnostic Laboratory
News
June 12, 2026

Thyrocare Expands Its Presence in Prayagraj with the Launch of Its New Diagnostic Laboratory

Thyrocare Technologies Limited has announced the set-up of its new diagnostic laboratory in Prayagraj, Uttar Pradesh, in association with SecondMedic. The new laboratory is equipped with advanced testing infrastructure and supported by trained professionals, enabling timely and error-free diagnostic results. It caters to both specialised and routine testing requirements, offering support to ongoing and preventive […]
Article by: IMT News Desk
AstraZeneca Gets CDSCO Approval for Trastuzumab Deruxtecan in HER2-Positive Breast Cancer
News
June 12, 2026

AstraZeneca Gets CDSCO Approval for Trastuzumab Deruxtecan in HER2-Positive Breast Cancer

AstraZeneca Pharma India Ltd. (AZPIL) announced that the Central Drugs Standard Control Organisation (CDSCO) has approved an additional indication for Trastuzumab Deruxtecan 100 mg/5 mL vial lyophilized powder for concentrate for solution for infusion, in combination with Pertuzumab as a first-line treatment for adult patients with unresectable or metastatic HER2-positive (IHC 3+ or ISH+) breast cancer. In India, HER2-positive breast […]
Article by: IMT News Desk